http://ift.tt/1fYdTKt
MUMBAI (Reuters) – India’s largest drug group Sun Pharmaceutical Industries Ltd said on Friday its U.S. sales might fall this year because of pressure on drug prices, signalling tough market conditions in the United States for generic drugmakers.
May 26, 2017 at 10:50PM
from
No comments:
Post a Comment